214
Views
0
CrossRef citations to date
0
Altmetric
POSTER EXTRACTS

Report on the Joint Workshop on the Relations between Health Inequalities, Ageing and Multimorbidity, Iceland, May 3–4, 2023

, ORCID Icon, , ORCID Icon, , , & ORCID Icon show all
Pages 9-22 | Received 11 Nov 2023, Accepted 13 Dec 2023, Published online: 16 Jan 2024

References

  • Partridge L, Deelen J, Slagboom PE. Facing up to the global challenges of ageing. Nature. 2018;561(7721):45–56.
  • Mackenbach JP. Health inequalities: persistence and change in European welfare states. First edition. ed. Oxford: Oxford University Press; 2019.
  • Sørensen HT, Pedersen L, van Es N, Büller HR, Horváth-Puhó E. Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study. Lancet Reg Health Eur. 2023;34:100739.

References

  • Berg J. Lumping and splitting. Science. 2018;359(6382):1309.
  • Mahendran M, Lizotte D, Bauer GR. Quantitative methods for descriptive intersectional analysis with binary health outcomes. SSM Popul Health. 2022;17:101032.
  • Bowleg L. Evolving Intersectionality Within Public Health: From Analysis to Action. Am J Public Health. 2021;111(1):88–90.
  • Alvidrez J, Greenwood GL, Johnson TL, Parker KL. Intersectionality in Public Health Research: A View From the National Institutes of Health. Am J Public Health. 2021;111(1):95–97.
  • Hankivsky O, Christoffersen A. Intersectionality and the determinants of health: a Canadian perspective. Critical Public Health. 2008;18(3):271–283.
  • Schäfer I, von Leitner EC, Schön G, et al. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One. 2010;5(12):e15941.
  • Burton PR, Hansell AL, Fortier I, et al. Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol. 2009;38(1):263–273.
  • Patel CJ, Ioannidis JP, Cullen MR, Rehkopf DH. Systematic assessment of the correlations of household income with infectious, biochemical, physiological, and environmental factors in the United States, 1999–2006. Am J Epidemiol. 2015;181(3):171–179.
  • Haendel MA, Chute CG, Bennett TD, et al. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. 2021;28(3):427–443.
  • Phillips R. The PRIME Registry Helps Thousands of Primary Care Clinicians Liberate EHR Data and Prepare for MIPS. J Am Board Fam Med. 2017;30(4):559–559.
  • Athey S, Wager S. Estimating Treatment Effects with Causal Forests: An Application. Observational Studies. 2019(2).
  • Jawadekar N, Kezios K, Odden MC, et al. Practical Guide to Honest Causal Forests for Identifying Heterogeneous Treatment Effects. Am J Epidemiol. 2023;192(7):1155–1165.
  • Cintron DW, Gottlieb LM, Hagan E, et al. A quantitative assessment of the frequency and magnitude of heterogeneous treatment effects in studies of the health effects of social policies. SSM Popul Health. 2023;22:101352.
  • Nguyen QC, Rehkopf DH, Schmidt NM, Osypuk TL. Heterogeneous Effects of Housing Vouchers on the Mental Health of US Adolescents. Am J Public Health. 2016;106(4):755–762.

References

References

  • Academy of Medical Sciences. Multimorbidity: a priority for global health research https://acmedsci.ac.uk/file-download/82222577. Accessed January 6, 2023.
  • Harrison C, Britt H, Miller G, Henderson J. Examining different measures of multimorbidity, using a large prospective cross-sectional study in Australian general practice. BMJ Open. 2014;4(7):e004694.
  • Head A, Fleming K, Kypridemos C, Schofield P, Pearson-Stuttard J, O'Flaherty M. Inequalities in incident and prevalent multimorbidity in England, 2004-19: a population-based, descriptive study. Lancet Healthy Longev. 2021;2(8):e489–e497.
  • Kivimäki M, Batty GD, Pentti J, et al. Association between socioeconomic status and the development of mental and physical health conditions in adulthood: a multi-cohort study. Lancet Public Health. 2020;5(3):e140–e149.
  • Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006;17(1):5–19.
  • Diderichsen F, Evans T, Whitehead M. The social basis of socioeconomic inequalities in health. In: Evans T, Whitehead M, Diderichsen F, Bhuiya A, Writh M, eds. Challenging Inequities in Health: From Ethics to Action. Cary: Oxford University Press, Incorporated; 2001:12–23.

References

  • Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;Spec No:80–94.
  • Phelan JC, Link BG, Tehranifar P. Social conditions as fundamental causes of health inequalities: theory, evidence, and policy implications. J Health Soc Behav. 2010;51 Suppl:S28–40.
  • Matthay EC, Duchowny KA, Riley AR, et al. Occupation and Educational Attainment Characteristics Associated With COVID-19 Mortality by Race and Ethnicity in California. JAMA Netw Open. 2022;5(4):e228406.
  • Chen YH, Matthay EC, Chen R, et al. Excess Mortality in California by Education During the COVID-19 Pandemic. Am J Prev Med. 2022;63(5):827–836.
  • Ho IS, Azcoaga-Lorenzo A, Akbari A, et al. Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies. Lancet Public Health. 2021;6(8):e587–e597.
  • MacRae C, McMinn M, Mercer SW, et al. The impact of varying the number and selection of conditions on estimated multimorbidity prevalence: A cross-sectional study using a large, primary care population dataset. PLoS Med. 2023;20(4):e1004208.
  • MacRae C, Mercer SW, Henderson D, et al. Age, sex, and socioeconomic differences in multimorbidity measured in four ways: UK primary care cross-sectional analysis. Br J Gen Pract. 2023;73(729):e249–e256.
  • Wei MY, Kabeto MU, Langa KM, Mukamal KJ. Multimorbidity and Physical and Cognitive Function: Performance of a New Multimorbidity-Weighted Index. J Gerontol A Biol Sci Med Sci. 2018;73(2):225–232.
  • Khanolkar AR, Chaturvedi N, Kuan V, et al. Socioeconomic inequalities in prevalence and development of multimorbidity across adulthood: A longitudinal analysis of the MRC 1946 National Survey of Health and Development in the UK. PLoS Med. 2021;18(9):e1003775.
  • Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry. 1997;54(10):915–922.
  • Siggaard T, Reguant R, Jørgensen IF, et al. Disease trajectory browser for exploring temporal, population-wide disease progression patterns in 7.2 million Danish patients. Nat Commun. 2020;11(1):4952.
  • VanderWeele TJ. Outcome-wide Epidemiology. Epidemiology. 2017;28(3):399–402.
  • Mackenbach JP. Health inequalities: persistence and change in European welfare states. First edition. ed. Oxford: Oxford University Press; 2019.
  • Mackenbach JP, Stirbu I, Roskam AJ, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;358(23):2468–2481.
  • Foverskov E, Petersen GL, Pedersen JLM, et al. Economic hardship over twenty-two consecutive years of adult life and markers of early ageing: physical capability, cognitive function and inflammation. Eur J Ageing. 2020;17(1):55–67.
  • Lee J, Phillips D, Wilkens J. Gateway to Global Aging Data: Resources for Cross-National Comparisons of Family, Social Environment, and Healthy Aging. J Gerontol B Psychol Sci Soc Sci. 2021;76(Suppl 1):S5–s16.

References

  • Reidpath DD, Allotey P. Measuring global health inequity. Int J Equity Health. 2007;6:16.
  • Friel S, Marmot MG. Action on the social determinants of health and health inequities goes global. Annual review of public health. 2011;32:225–236.
  • Braveman P, Gottlieb L. The social determinants of health: it's time to consider the causes of the causes. Public Health Rep. 2014;129 Suppl 2(Suppl 2):19–31.
  • Boen C, Keister L, Aronson B. Beyond Net Worth: Racial Differences in Wealth Portfolios and Black-White Health Inequality across the Life Course. J Health Soc Behav. 2020;61(2):153–169.
  • Diderichsen F. A Conceptual Framework for Action on the Social Determinants of Health. World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/44489/9789241500852_eng.pdf. Published 2010. Accessed.
  • Burton-Jeangros C, Cullati S, Sacker A. A Life Course Perspective on Health Trajectories and Transitions. In: Cham: Springer International Publishing Imprint: Springer; 2015. http://dx.doi.org/10.1007/978-3-319-20484-0.
  • Dauphiné DC, Ferreccio C, Guntur S, et al. Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int Arch Occup Environ Health. 2011;84(6):591–600.
  • Bush A. Impact of early life exposures on respiratory disease. Paediatr Respir Rev. 2021;40:24–32.
  • Mostafalou S, Abdollahi M. Pesticides and human chronic diseases: evidences, mechanisms, and perspectives. Toxicol Appl Pharmacol. 2013;268(2):157–177.
  • Boekelheide K, Blumberg B, Chapin RE, et al. Predicting later-life outcomes of early-life exposures. Environ Health Perspect. 2012;120(10):1353–1361.
  • Clifford A, Lang L, Chen R, Anstey KJ, Seaton A. Exposure to air pollution and cognitive functioning across the life course--A systematic literature review. Environ Res. 2016;147:383–398.
  • Deckers K, Cadar D, van Boxtel MPJ, Verhey FRJ, Steptoe A, Köhler S. Modifiable Risk Factors Explain Socioeconomic Inequalities in Dementia Risk: Evidence from a Population-Based Prospective Cohort Study. J Alzheimers Dis. 2019;71(2):549–557.
  • Hajat A, Kaufman JS, Rose KM, Siddiqi A, Thomas JC. Do the wealthy have a health advantage? Cardiovascular disease risk factors and wealth. Soc Sci Med. 2010;71(11):1935–1942.
  • Berthon BS, Wood LG. Nutrition and respiratory health--feature review. Nutrients. 2015; 7(3):1618–1643.

References

  • Academy of Medical Sciences. Multimorbidity: a priority for global health research https://acmedsci.ac.uk/file-download/82222577. Accessed January 6, 2023.
  • Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–e125.
  • Feigin VL, Vos T, Nichols E, et al. The global burden of neurological disorders: translating evidence into policy. The Lancet Neurology. 2020;19(3):255–265.
  • World Health Organization. Global status report on the public health response to dementia. Published 2021. Accessed January 2, 2024.
  • Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011;377(9770):1019–1031.
  • Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer's disease. Lancet. 2021; 397(10284):1577–1590.
  • Schneider JA. Neuropathology of dementia disorders. Continuum (Minneap Minn). 2022;28(3):834–851.
  • Yu L, Boyle PA, Dawe RJ, Bennett DA, Arfanakis K, Schneider JA. Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology. 2020; 94(2):e142–e152.
  • Xue M, Xu W, Ou YN, et al. Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;55: 100944.
  • Adelborg K, Horváth-Puhó E, Ording A, Pedersen L, Sørensen HT, Henderson VW. Heart failure and risk of dementia: a Danish nationwide population-based cohort study. Eur J Heart Fail. 2017;19(2):253–260.
  • Tran EM, Stefanick ML, Henderson VW, et al. Association of visual impairment with risk of incident dementia in a Women's Health Initiative population. JAMA Ophthalmol. 2020;138(6):624–633.
  • Kjaergaard AD, Ellervik C, Witte DR, Nordestgaard BG, Frikke-Schmidt R, Bojesen SE. Kidney function and risk of dementia: Observational study, meta-analysis, and two-sample mendelian randomization study. Eur J Epidemiol. 2022;37(12):1273–1284.
  • Elser H, Horváth-Puhó E, Gradus JL, et al. Association of early-, middle-, and late-life depression with incident dementia in a Danish cohort. JAMA Neurol. 2023;80(9):949–958.
  • Gradus JL, Horváth-Puhó E, Lash TL, et al. Stress disorders and dementia in the Danish population. Am J Epidemiol. 2019;188(3):493–499.
  • Wang AY, Hu HY, Ou YN, et al. Socioeconomic status and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 39 prospective studies. J Prev Alzheimers Dis. 2023;10(1):83–94.
  • Zhao YL, Qu Y, Ou YN, Zhang YR, Tan L, Yu JT. Environmental factors and risks of cognitive impairment and dementia: a systematic review and meta-analysis. Ageing Res Rev. 2021;72:101504.
  • Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–446.
  • Sabia S, Fayosse A, Dumurgier J, et al. Association of sleep duration in middle and old age with incidence of dementia. Nat Commun. 2021;12(1):2289.
  • Tsoy E, Kiekhofer RE, Guterman EL, et al. Assessment of racial/ethnic disparities in timeliness and comprehensiveness of dementia diagnosis in California. JAMA Neurol. 2021;78(6):657–665.
  • Jones IR. Social class, dementia and the fourth age. Sociol Health Illn. 2017;39(2):303–317.
  • Shiekh SI, Cadogan SL, Lin LY, Mathur R, Smeeth L, Warren-Gash C. Ethnic differences in dementia risk: A systematic review and meta-analysis. J Alzheimers Dis. 2021;80(1):337–355.
  • Powell WR, Zuelsdorff M, Keller SA, et al. Association of neighborhood-level disadvantage with neurofibrillary tangles on neuropathological tissue assessment. JAMA Netw Open. 2022;5(4):e228966.